首页> 美国卫生研究院文献>International Journal of Medical Sciences >Evaluation of Antiviral Activities of Four Local Malaysian Phyllanthus Species against Herpes Simplex Viruses and Possible Antiviral Target
【2h】

Evaluation of Antiviral Activities of Four Local Malaysian Phyllanthus Species against Herpes Simplex Viruses and Possible Antiviral Target

机译:评估马来西亚四个当地的余甘子种对单纯疱疹病毒的抗病毒活性和可能的​​抗病毒目标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nucleoside analogues such as acyclovir are effective antiviral drugs against herpes simplex virus infections since its introduction. However, with the emergence of acyclovir-resistant HSV strains particularly in immunocompromised patients, there is a need to develop an alternative antiherpetic drug and plants could be the potential lead. In this study, the antiviral activity of the aqueous extract of four Phyllanthus species were evaluated against herpes simplex virus type-1 (HSV-1) and HSV-2 in Vero cells by quantitative PCR. The protein expressions of untreated and treated infected Vero cells were studied by 2D-gel electrophoresis and Western blot. This is the first study that reported the antiviral activity of P. watsonii. P. urinaria was shown to demonstrate the strongest antiviral activity against HSV-1 and HSV-2, with SI >33.6. Time-of-addition studies suggested that the extract may act against the early infection stage and the replication stage. Protein expression studies indicated that cellular proteins that are involved in maintaining cytoskeletal structure could be potential target for development of antiviral drugs. Preliminary findings indicated that P. urinaria demonstrated potent inhibitory activity against HSV. Hence, further studies such as in vivo evaluation are required for the development of effective antiherpetic drug.
机译:自引入以来,核苷类似物(例如阿昔洛韦)是有效的抗单纯疱疹病毒感染的抗病毒药物。但是,随着对阿昔洛韦耐药的HSV菌株的出现,特别是在免疫功能低下的患者中,有必要开发一种替代的抗疱疹药物,而植物可能是潜在的领先者。在这项研究中,通过定量PCR评价了四种余甘菊水提物对Vero细胞中单纯疱疹病毒1型(HSV-1)和HSV-2的抗病毒活性。通过2D凝胶电泳和Western印迹研究未经处理和经处理的感染Vero细胞的蛋白质表达。这是第一项报道华氏疟原虫抗病毒活性的研究。尿小球藻显示出对HSV-1和HSV-2的最强抗病毒活性,SI> 33.6。添加时间研究表明,提取物可能对早期感染阶段和复制阶段起作用。蛋白质表达研究表明,参与维持细胞骨架结构的细胞蛋白质可能是开发抗病毒药物的潜在目标。初步发现表明,尿小球菌对HSV具有强抑制作用。因此,开发有效的抗疱疹药物需要进一步的研究,例如体内评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号